Molecular and Imaging Biomarkers; Precision Cardiovascular Medicine

Introduction

The purpose of this program is to coordinate basic and clinical research aimed to investigating biomarkers from blood and imaging studies that are not part of the routine clinical evaluation of cardiovascular (CV) patients but that can 1) characterize the clinical and biological uniqueness of an individual patient or a group of patients sharing a given phenotype, and 2) assist decision making and modify clinical care with incremental value with respect to standard available diagnostic tests or therapeutic evaluation procedures.

Lines of research

The research in this program is organized in two main lines:

1) Evaluation of Known Biomarkers with the goal to assess the performance of isolated or combined biomarkers already described as tools for phenotyping CV patients, or staging the extent and prognosis of CV conditions, or personalizing and monitoring the response to therapeutic CV interventions.

2) Identification of Novel Biomarkers with the goal to characterize candidate circulating and imaging biomarkers indicators of normal CV biological processes or CV pathological processes, and that can be potentially used for the clinical handling of CV patients because enable repeated and accurate measurements with a rapid turnaround time at reasonable cost.

Coordinador de programa

Javier Diez, MD, PhD

Director, Program of Cardiovascular Diseases

Center for Applied Medical Research

Head of Research and Innovation, Department of Cardiology and Cardiac Surgery, University Clinic, University of Navarra

C/ Avda. Pío XII 55, 31008 Pamplona

Tel. 00 34 948 194700,

[email protected]

Grupos adscritos